Advanced search
Publication Cover
Current Medical Research and Opinion Volume 35, 2019 - Issue 3
Submit an article Journal homepage
465
Views
5
CrossRef citations to date
0
Altmetric
Psychiatry

The prospective economic impact of once monthly paliperidone palmitate versus oral atypical antipsychotics in Medicaid patients with schizophrenia

Antoine C. El KhouryJanssen Scientific Affairs LLC, Titusville, NJ, USA; Correspondence[email protected]
,
Dominic PilonAnalysis Group Inc., Montréal, QC, Canada;
,
Laura MorrisonAnalysis Group Inc., Montréal, QC, Canada;
,
Nina ShakAnalysis Group Inc., Menlo Park, CA, USA
,
Maude Vermette-LaformeAnalysis Group Inc., Montréal, QC, Canada;
,
Tony B. AmosJanssen Scientific Affairs LLC, Titusville, NJ, USA;
,
Edward KimJanssen Scientific Affairs LLC, Titusville, NJ, USA;
&
Patrick LefebvreAnalysis Group Inc., Montréal, QC, Canada;
show all
Pages 395-405 | Received 12 Oct 2018, Accepted 07 Dec 2018, Published online: 03 Jan 2019

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Antoine El Khoury, Charmi Patel, Ahong Huang, Li Wang & Richa Bashyal. (2019) Transitioning from oral risperidone or paliperidone to once-monthly paliperidone palmitate: a real-world analysis among Veterans Health Administration patients with schizophrenia who have had at least one prior hospitalization. Current Medical Research and Opinion 35:12, pages 2159-2168.
Read now

Articles from other publishers (4)

Laura MorrisonDee LinCarmela BensonIsabelle GhelerterMaude Vermette-LaformePatrick LefebvreDominic Pilon. (2023) Projecting the economic outcomes of switching patients with schizophrenia from oral atypical antipsychotics to once-monthly, once-every-3-months, and once-every-6-months paliperidone palmitate. Journal of Managed Care & Specialty Pharmacy 29:2, pages 161-171.
Crossref
Dasom Lee, Boung Chul Lee, Soo-Hee Choi, Do-Hyung Kang, Duk-In Jon & Myung Hun Jung. (2020) Effects of Paliperidone Palmitate on Healthcare Utilization and Costs for Patients with Schizophrenia: A Claim-based Mirror-image Study in South Korea. Clinical Psychopharmacology and Neuroscience 18:2, pages 303-310.
Crossref
Charmi Patel, Bruno Emond, Marie-Hélène Lafeuille, Aurélie Côté-Sergent, Patrick Lefebvre, Neeta Tandon & Antoine C. El Khoury. (2019) Real-World Analysis of Switching Patients with Schizophrenia from Oral Risperidone or Oral Paliperidone to Once-Monthly Paliperidone Palmitate. Drugs - Real World Outcomes 7:1, pages 19-29.
Crossref
Antoine C. El KhouryDominic PilonLaura MorrisonNina Shak, Amanda LlanezaEdward KimPatrick Lefebvre. (2020) Projecting the Long-Term Economic Impact of Once-Monthly Paliperidone Palmitate Versus Oral Atypical Antipsychotics in Medicaid Patients with Schizophrenia. Journal of Managed Care & Specialty Pharmacy 26:2, pages 176-185.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.